ABSTRACT
Plasma fibronectin (Fbn) was assessed daily in 9 men admitted to the cardiology care unit for uncomplicated acute myocardial infarction (AMI). In a control group of twenty healthy men, plasma Fbn was 0.290ñ 0.0417g/l-1 (meanñSD). In 6 hypertensive AMI patients, Fbn levels were increased to a maximum of 0.461ñ0.0294 g/l-1 at day five (5.5 ñ 0.84 days) and returned to the range of the control group values 56 ñ 32.8 afterwards. Three normotensive patients had higher Fbn results without returning to the control group range at the end of the hospitalization (0.734 ñ 0.209 gl-1). Plasma Fbn could in part be implicated in the repair process and/or in the limitation of the cardiac necrosis extension. Moreover, it seems that a link exists between plasma Fbn kinetics and hypertension and/or normotension during uncomplicated AMI.
Subject(s)
Adult , Humans , Male , Fibronectins/metabolism , Hypertension/metabolism , Myocardial Infarction/metabolism , Fibronectins/blood , Myocardial Infarction/blood , Nephelometry and TurbidimetryABSTRACT
Diabetes mellitus is now among the ten leading causes of death in the Caribbean. Studies of the prevalence of dysglycaemic disorder and risk factors for diabetes are necessary in order to design and implement tailored prevention programmes. The present study is of a representative sample of the adult population in Guadeloupe. The estimated prevalence of diabetes is 5.8% in adults, and that of impaired glucose tolerance is 7.4%. The percentage of insulin-treated patients is low, 14% of diabetics. The principal risk factors of diabetes,as classically recognised, are shown to operate. At the individual level, the presence of a diabetic parent is greater relative risk factor than obesity. However, considering the large percentage of persons who are obese, obesity seems to be the principal factor at which a primary prevention programme at the community level should be aimed, in order to limit the incidence of hyperglycaemic states
Subject(s)
Humans , Adult , Middle Aged , Male , Female , Diabetes Mellitus/epidemiology , Glucose Tolerance Test , Risk Factors , Diabetes Mellitus/prevention & control , Diabetes Mellitus/epidemiology , Hyperglycemia/epidemiologyABSTRACT
We compare the relative validity of HbA1c and fructosamine as indices of lon-term vlood glucose levels in populations with a common occurrence of haemoglobinopathies. In these patients, HbA1c levels are lower than AbA1c levels in non-haemoglobinopathy patients and do not reflect the glucidic status of the patients, unlike the fructosamine assay. This last test has a good potential to be used as a mass screening test for diabetes mellitus in the populations (Africa, Caribbean, USA) in either homozygous or heterozygous haemoglobinopathy patients. Moreover, fructosamine presents numerous technical advantages which facilitate the screening